Literature DB >> 12589428

Biallelic expression of HRAS and MUCDHL in human and mouse.

Michael Goldberg1, Michelle Wei, Luwa Yuan, Vundavalli V Murty, Benjamin Tycko.   

Abstract

At least eight genes clustered in 1 Mb of DNA on human chromosome (Chr) 11p15.5 are subject to parental imprinting, with monoallelic expression in one or more tissues. Orthologues of these genes show conserved linkage and imprinting on distal Chr 7 of mice. The extended imprinted region has a bipartite structure, with at least two differentially methylated DNA elements (DMRs) controlling the imprinting of two sub-domains. We previously described three biallelically expressed genes ( MRPL23, 2G7 and TNNT3) in 100 kb of DNA immediately downstream of the imprinted H19 gene, suggesting that H19 marks one border of the imprinted region. Here we extend this analysis to two additional downstream genes, HRAS and MUCDHL (mu-protocadherin). We find that these genes are biallelically expressed in multiple fetal and adult tissues, both in humans and in mice. The mouse orthologue of a third gene, DUSP8, located between H19 and MUCDHL, is also expressed biallelically. The DMR immediately upstream of H19 frequently shows a net gain of methylation in Wilms tumors, either via Chr 11p15.5 loss of heterozygosity (LOH) or loss of imprinting (LOI), but changes in methylation in CpG-rich sequences upstream and within the MUCDHL gene are rare in these tumors and do not correlate with LOH or LOI. These findings are further evidence for a border of the imprinted region immediately downstream of H19, and the data allow the construction of an imprinting map that includes more than 20 genes, distributed over 3 Mb of DNA on Chr 11p15.5.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12589428     DOI: 10.1007/s00439-003-0907-7

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  37 in total

Review 1.  The impact of genomic imprinting for neurobehavioral and developmental disorders.

Authors:  R D Nicholls
Journal:  J Clin Invest       Date:  2000-02       Impact factor: 14.808

2.  Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms.

Authors:  M Orita; H Iwahana; H Kanazawa; K Hayashi; T Sekiya
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

3.  Lack of imprinting of the human dopamine D4 receptor (DRD4) gene.

Authors:  S Cichon; M M Nöthen; H K Wolf; P Propping
Journal:  Am J Med Genet       Date:  1996-04-09

4.  Methylation sequencing analysis refines the region of H19 epimutation in Wilms tumor.

Authors:  M A Frevel; S J Sowerby; G B Petersen; A E Reeve
Journal:  J Biol Chem       Date:  1999-10-08       Impact factor: 5.157

5.  Epigenetic lesions at the H19 locus in Wilms' tumour patients.

Authors:  T Moulton; T Crenshaw; Y Hao; J Moosikasuwan; N Lin; F Dembitzer; T Hensle; L Weiss; L McMorrow; T Loew; W Kraus; W Gerald; B Tycko
Journal:  Nat Genet       Date:  1994-07       Impact factor: 38.330

6.  E-cadherin germline mutations in familial gastric cancer.

Authors:  P Guilford; J Hopkins; J Harraway; M McLeod; N McLeod; P Harawira; H Taite; R Scoular; A Miller; A E Reeve
Journal:  Nature       Date:  1998-03-26       Impact factor: 49.962

7.  Characterization of a 500-kb contig spanning the region between c-Ha-Ras and MUC2 on chromosome 11p15.5.

Authors:  M J Paris; B R Williams
Journal:  Genomics       Date:  2000-10-15       Impact factor: 5.736

8.  Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands.

Authors:  J G Herman; J R Graff; S Myöhänen; B D Nelkin; S B Baylin
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-03       Impact factor: 11.205

9.  Monoallelic expression of the human H19 gene.

Authors:  Y Zhang; B Tycko
Journal:  Nat Genet       Date:  1992-04       Impact factor: 38.330

10.  Epigenetic changes encompassing the IGF2/H19 locus associated with relaxation of IGF2 imprinting and silencing of H19 in Wilms tumor.

Authors:  T Taniguchi; M J Sullivan; O Ogawa; A E Reeve
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-14       Impact factor: 11.205

View more
  4 in total

1.  Epigenetic silencing of the MUPCDH gene as a possible prognostic biomarker for cyst growth in ADPKD.

Authors:  Yu Mi Woo; Yubin Shin; Jung-Ah Hwang; Young-Hwan Hwang; Sunyoung Lee; Eun Young Park; Hyun Kyung Kong; Hayne Cho Park; Yeon-Su Lee; Jong Hoon Park
Journal:  Sci Rep       Date:  2015-10-14       Impact factor: 4.379

2.  Loss of cadherin related family member 5 (CDHR5) expression in clear cell renal cell carcinoma is a prognostic marker of disease progression.

Authors:  Felix Marius Bläsius; Sebastian Meller; Carsten Stephan; Klaus Jung; Jörg Ellinger; Michael O Glocker; Hans-Jürgen Thiesen; Yuri Tolkach; Glen Kristiansen
Journal:  Oncotarget       Date:  2017-08-24

3.  Parental origin of sequence variants associated with complex diseases.

Authors:  Augustine Kong; Valgerdur Steinthorsdottir; Gisli Masson; Gudmar Thorleifsson; Patrick Sulem; Soren Besenbacher; Aslaug Jonasdottir; Asgeir Sigurdsson; Kari Th Kristinsson; Adalbjorg Jonasdottir; Michael L Frigge; Arnaldur Gylfason; Pall I Olason; Sigurjon A Gudjonsson; Sverrir Sverrisson; Simon N Stacey; Bardur Sigurgeirsson; Kristrun R Benediktsdottir; Helgi Sigurdsson; Thorvaldur Jonsson; Rafn Benediktsson; Jon H Olafsson; Oskar Th Johannsson; Astradur B Hreidarsson; Gunnar Sigurdsson; Anne C Ferguson-Smith; Daniel F Gudbjartsson; Unnur Thorsteinsdottir; Kari Stefansson
Journal:  Nature       Date:  2009-12-17       Impact factor: 49.962

4.  In silico regulatory analysis for exploring human disease progression.

Authors:  Dustin T Holloway; Mark Kon; Charles DeLisi
Journal:  Biol Direct       Date:  2008-06-18       Impact factor: 4.540

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.